ACS Biotech articles

ACS Biotech has chosen the participatory economy to reaffirm its values and allow investors to give meaning to their savings while financing the real economy on a major public health issue.

There are now nearly 230 million patients with osteoarthritis in the world and 4 million additional cartilage lesions per year. Osteoarthritis results anatomically in the destruction of cartilage in the joints (knee, hip, etc.), which causes severe pain and a significant reduction in mobility.

ACS Biotech is an innovative biotechnology company created in 2013 by Pascale Hazot, Doctor of Chemistry and MBA from EM Lyon. Specialized in regenerat